通过抗体对抗COVID-19变种来定义中和和
Nikhil Kumar Tulsian1,2, Raghuvamsi Venkata Palur3,4, Xinlei Qian5
1Department of Biological Sciences, National University of Singapore, Singapore, 117543, Singapore. nikhilkt.science@gmail.com.
Nature communications
|November 1, 2023
概括
针对SARS-CoV-2尖端蛋白的新型人类抗体揭示了突变如何影响抗体有效性. 了解这些相互作用有助于设计更好的COVID-19抗病毒策略.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 结构生物学 结构生物学
背景情况:
- 随着SARS-CoV-2变种的出现,由于免疫逃脱和抗体效率降低,造成了挑战.
- 在抗体结合时,SARS-CoV-2的抗体中和受到Spike蛋白的四级变化的影响.
研究的目的:
- 研究与SARS-CoV-2尖刺蛋白结合的新型人类抗体的结构动态和质效应.
- 为了识别表位热点,并将尖端蛋白的动态与抗体中和强度相关联.
- 分析SARS-CoV-2变种 (武汉-胡-1,三角形,欧米克龙) 对抗体诱导的尖端蛋白形状变化的影响.
主要方法:
- 对抗体-斯派克三元体相互作用的构造动力学和全性扰动的分析.
- 标识表位热点及其与尖峰动态的相关性.
- 在不同SARS-CoV-2变异中对Spike蛋白中抗体诱导的构造变化的比较分析.
主要成果:
- 确定了表位热点和相关的尖峰动态,可以区分弱,中等和强中和抗体.
- 证明了武汉-胡-1,三角形和Omicron变异中的突变如何改变抗体诱导的尖端形状变化,从而降低了抗体的有效性.
- 表明具有相似结合亲和力的抗体可以诱导Spike蛋白上明显的全效应 (破坏稳定或稳定),影响中和.
结论:
- 对人类抗体对抗SARS-CoV-2的功能机制和协同作用的机制性见解.
- 这些发现可以指导设计更有效的抗病毒策略和基于抗体的COVID-19治疗方法.
- 了解尖端蛋白的动力学和全调节对于克服变异驱动的免疫逃脱至关重要.
相关概念视频
00:42Cross-reactivity
31.2K
Overview
31.2K
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:41Affinity and Avidity
36.2K
Overview
36.2K
01:25Antibody Structure and Classes
926
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
926
01:10Antibody Structure
60.2K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.2K
01:36Humoral Immune Responses
72.8K
Overview
72.8K